Cargando…

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction

AIMS: There is paucity of clinical data comparing continuous infusion (CI) with bolus injection (BI) of intravenous loop diuretics in patients with acute decompensated heart failure (ADHF) and chronic renal dysfunction. This study aimed to compare the efficacy and safety of CI versus BI intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zhigui, Jiang, Xinxin, Chen, Jianguo, He, Dongyuan, Xie, Xiaohui, Lu, Yunan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120396/ https://www.ncbi.nlm.nih.gov/pubmed/33689236 http://dx.doi.org/10.1002/ehf2.13286

Ejemplares similares

Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction: A protocol for systematic review and meta-analysis
por: Chen, Siqi, et al.
Publicado: (2021)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Comparison of continuous infusion and intermittent boluses of furosemide in acute heart failure: A protocol for systematic review and meta-analysis
por: Wang, Tao, et al.
Publicado: (2021)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
por: Rahhal, Alaa, et al.
Publicado: (2019)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

The influence of intense intermittent versus moderate continuous exercise on postprandial lipemia
por: Ferreira, Aparecido Pimentel, et al.
Publicado: (2011)

Continuous versus bolus furosemide therapy in critically ill patients with fluid overload
por: Ostermann, M, et al.
Publicado: (2002)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
por: Herrera-Leaño, Nancy, et al.
Publicado: (2023)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution
por: Sica, Domenic A., et al.
Publicado: (2018)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
por: Mikami, Takafumi, et al.
Publicado: (2021)

Role and Mechanism of Epithelial-Mesenchymal Transition Mediated by Inflammatory Stress-Induced TGF-β1 in Promoting Arteriovenous Fistula Stenosis
por: Duan, Qingqing, et al.
Publicado: (2022)

Comparison between continuous versus bolus furosemide administration in oliguric postoperative paediatric cardiac patients
por: Taylor, D, et al.
Publicado: (2003)

Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis
por: Huang, Youpan, et al.
Publicado: (2022)

Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial
por: Balsam, Paweł, et al.
Publicado: (2020)

Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial
por: Palazzuoli, Alberto, et al.
Publicado: (2014)

Effect of continuous furosemide infusion on outcome of acute kidney injury
por: Ni, Jie, et al.
Publicado: (2019)

Renal Dysfunction in Acute Heart Failure
por: Han, Seong Woo, et al.
Publicado: (2011)

A new paradigm for the treatment of volume overload in heart failure-combined effect of tolvaptan with furosemide
por: Okamoto, Hiroshi
Publicado: (2013)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis
por: Li, Zuoqing, et al.
Publicado: (2022)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

Role of the Furosemide Stress Test in Renal Injury Prognosis
por: Coca, Armando, et al.
Publicado: (2020)

Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection
por: Sager, Rana, et al.
Publicado: (2020)

Chronic furosemide administration blunts renal BOLD magnetic resonance response to an acute furosemide stimulus in patients being evaluated for renal artery revascularization
por: Hall, Michael E, et al.
Publicado: (2013)

Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials
por: Bove, Tiziana, et al.
Publicado: (2018)

Effects of furosemide and tadalafil in both conventional and nanoforms against adenine-induced chronic renal failure in rats
por: Hamdy, Moustafa Mahmoud, et al.
Publicado: (2022)

Comparison of continuous epidural infusion and programmed intermittent epidural bolus in labor analgesia
por: Lin, Yunan, et al.
Publicado: (2016)

Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
por: CHEN, ZHI-HAO, et al.
Publicado: (2016)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

Dose of furosemide before admission predicts diuretic efficiency and long‐term prognosis in acute heart failure
por: Blázquez‐Bermejo, Zorba, et al.
Publicado: (2021)

Autonomic Dysfunction in Heart Failure and Renal Disease
por: Phillips, Jacqueline Kathleen
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_64bvdhlcrvg8dk952ivpgtgj0u